|The IFN beta ifnb1 (Catalog #MBS530525) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The IFN beta antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s IFN beta can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blot (WB). Researchers should empirically determine the suitability of the IFN beta ifnb1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The IFN beta ifnb1 product has the following accession number(s) (GI #4504603) (NCBI Accession #NP_002167.1) (Uniprot Accession #P01574). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal IFN beta antibody.
Biological Significance: Interferons (IFNs) are proteins made and released by lymphocytes in response to the presence of pathogens-such as viruses, bacteria, or parasites-or tumor cells. They allow communication between cells to trigger the protective defenses of the immune system that eradicate pathogens or tumors.
Bioactivity: Binds to human interferon beta with high affinity. Immunogen: IFN beta antibody was raised in mouse using human interferon beta as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing IFN beta are readily searchable from our website. Different antibodies against the same target such as IFN beta may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Carcinoma, Immune System Diseases, Inflammation, Lung Diseases, Lung Neoplasms, Melanoma, Multiple Sclerosis, Necrosis, Neoplasms, Experimental, Pancreatic Neoplasms are some of the diseases may be linked to IFN beta antibody. IFN beta also interacts with the following gene(s): IFNAR1, IFNAR2, IRF1, IRF3, IRF7, SOCS3, STAT1, STAT2. The following patways have been known to be associated with this gene.